Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn E Griffith

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
BMJ (Clinical Research Ed.)|July 26, 2008
Atrial fibrillationKathryn E Griffith, Maurice Pye
Trials|April 22, 2022
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney diseaseHugh Gallagher, Jennifer Dumbleton, Tom Maishman, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
BMJ (Clinical Research Ed.)|July 26, 2008
Atrial fibrillationKathryn E Griffith, Maurice Pye
Trials|April 22, 2022
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney diseaseHugh Gallagher, Jennifer Dumbleton, Tom Maishman, et al.
Pageof 1